phase i-ii trial of carboplatin (cbdca) an vinorelbine (vnr) in stage iv non-small cell lung cancer (nsclc). a pilot study of spanish lung cancer groupdoi:10.1016/S0959-8049(99)81456-7Massutí, B.Barneto, I.Meana, J.A.Herrero, J....
Vinorelbine (VNR), Gemcitabine (GEM), and Carboplatin (CBDCA) as a primary treatment modality in non-small-cell lung cancer (NSCLC) patients with BM. ... G Bernardo,Q Cuzzoni,MR Strada,... - 《Cancer Investigation》 被引量: 215发表: 2002年 Final overall survival results of NEJ002, a...
the blood-brain barrier, we addressed the role of a new combination regimen with Vinorelbine (VNR), Gemcitabine (GEM), and Carboplatin (CBDCA) as a primary treatment modality in non-small-cell lung cancer (NSCLC) patients with BM... G Bernardo,Q Cuzzoni,MR Strada,... - 《Cancer Investig...
6562 POSTER First-line treatment with vinorelbine (VNR) plus carboplatin (CBDCA) for patients with advanced non-small-cell lung cancer (NSCLC): MAP4/OP18 mRNA expression as marker predictive of response - ResearchGatedoi:10.1016/S1359-6349(07)71390-3Galan, A....